Every round on record, with the sources behind each and the investors on them.
A genomic medicine developer
whitelabgx.comLinkedInParis, FranceBiotechYC W22Founded 201952 people
10 sources · checked 1 time, last 1d ago
EU-Startups reports €23.2 million ($26 million); the company's release reports $26 million, which is used. The headquarters source identifies Paris but does not state a country.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B | $26M $37M to date | 2026-10-05 | AVP | 9 outlets. #46 in Trending |
10 sources · checked 1 time, last 1d ago [ VERIFIED · CORRECTED ] read against 4 of 10 sources
EU-Startups reports €23.2 million ($26 million); the company's release reports $26 million, which is used. The headquarters source identifies Paris but does not state a country. | ||||
WhiteLab Genomics uses AI and computational biology to design and optimize the delivery vehicles and genetic payloads that pharmaceutical and biotechnology partners need to develop genomic medicines.
LinkedIn via Alexandria from ycombinator.com
Checked against 12 sources yesterday
Also named as backers in company research: Y Combinator